Novavax Announces Pricing of $65 Million Public Offering of Common Stock
- Written by PR Newswire
![]() |
GAITHERSBURG, Md., Dec. 16, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the pricing of an underwritten public offering to sell 6,500,000 shares of its common stock at a public...
Read more: Novavax Announces Pricing of $65 Million Public Offering of Common Stock















